SmPC - Ferrous sulfate Tablets BP 200mg: Change history
View Summary of Product Characteristics (SmPC - Ferrous sulfate Tablets BP 200mg)
Last updated on this site: 23 Jul 2026
Update to section 4.2 of the SmPC to bring paediatric dosage information in line with the current BNFC recommendations. Consequently, the PIL and the label have been updated.
SmPC sections updated: 4.2 and 10
Variation approval date: 15/07/2026
Last updated on this site: 23 Jul 2026
Update to section 4.2 of the SmPC to bring paediatric dosage information in line with the current BNFC recommendations. Consequently, the PIL and the label have been updated.
SmPC sections updated: 4.2 and 10
Variation approval date: 15/07/2026
-
Changes: (Updated: 23 Jul 2026)
Update to section 4.2 of the SmPC to bring paediatric dosage information in line with the current BNFC recommendations. Consequently, the PIL and the label have been updated.
SmPC sections updated: 4.2 and 10
Variation approval date: 15/07/2026
-
Changes: (Updated: 11 Mar 2026)
To register change in immediate packaging of the finished product - add Aluminium (25μm)/paper (25g/m2) foil as an alternative to the already registered Aluminium (9μm)/glassine paper (35g/m2) foil. Consequently section 6.5 of the SPC has been updated.
-
Changes: (Updated: 31 Jul 2023)
Variation Description: To update section 2 of the SmPC to bring in line with the MHRA letter request to include the quantities of glucose, lactose and sucrose per tablet as they are excipients with known effects.
SmPC sections updated – 2 and 10.
-
Changes: (Updated: 21 Sep 2022)
Initial upload